Spots Global Cancer Trial Database for Dermaprazole Cream for Radiation Dermatitis in Head and Neck Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Dermaprazole Cream for Radiation Dermatitis in Head and Neck Cancer
Official Title: A Phase II Clinical Trial of Dermaprazole Cream for Radiation Dermatitis in Head and Neck Cancer Patients (CTMS# 20-0147)
Study ID: NCT04865731
Conditions
Study Description
Brief Summary: In this study, the study team seek to conduct a pilot clinical study to evaluate the safety and efficacy of a reformulated proton pump inhibitor (PPI) cream (Dermaprazole) in definitive head and neck cancer (HNC) patients.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Mays Cancer Center, San Antonio, Texas, United States
Contact Details
Name: Timothy Wagner, MD
Affiliation: The University of Texas Health Science Center - Mays Cancer Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
